RCM
RA Capital Management Portfolio holdings
AUM
$5.94B
This Quarter Return
-11.75%
1 Year Return
+18.15%
3 Year Return
+417.5%
5 Year Return
+458.13%
10 Year Return
+21,247.51%
AUM
$1.72B
AUM Growth
+$1.72B
(-8.2%)
Cap. Flow
+$165M
Cap. Flow
% of AUM
9.61%
Top 10 Holdings %
Top 10 Hldgs %
73.79%
Holding
30
New
4
Increased
9
Reduced
2
Closed
5
Top Buys
| 1 |
THOR
Synthorx, Inc. Common Stock
THOR
|
$169M |
| 2 |
ORTX
Orchard Therapeutics plc American Depositary Shares
ORTX
|
$76.2M |
| 3 |
EIGR
Eiger BioPharmaceuticals, Inc.
EIGR
|
$24.5M |
| 4 |
Moderna
MRNA
|
$23.1M |
| 5 |
ZGNX
Zogenix, Inc.
ZGNX
|
$18.4M |
Top Sells
| 1 |
ECYT
Endocyte, Inc. Common Stock
ECYT
|
$110M |
| 2 |
SAGE
Sage Therapeutics
SAGE
|
$49.6M |
| 3 |
PGNX
Progenics Pharmaceuticals Inc
PGNX
|
$19M |
| 4 |
Apellis Pharmaceuticals
APLS
|
$16M |
| 5 |
DRNA
Dicerna Pharmaceuticals, Inc.
DRNA
|
$15.8M |
Sector Composition
| 1 | Healthcare | 95.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Wave Life Sciences
WVE
$1.53B
| $316M | 18.38% | 7,512,049 | – | – |
|
2
Ascendis Pharma
ASND
$11.8B
| $266M | 15.46% | 4,240,536 | – | – |
|
|
THOR
3
DELISTED
Synthorx, Inc. Common Stock
THOR
| $169M | 9.84% | +9,724,598 | New | +$169M |
|
|
ZGNX
4
DELISTED
Zogenix, Inc.
ZGNX
| $86.9M | 5.06% | 2,382,168 +503,400 | +27% | +$18.4M |
|
5
BioCryst Pharmaceuticals
BCRX
$1.74B
| $86M | 5.01% | 10,660,349 +1,425,657 | +15% | +$11.5M |
|
|
ORTX
6
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
| $76.2M | 4.44% | +4,845,933 | New | +$76.2M |
|
7
InflaRx
IFRX
$108M
| $75.8M | 4.41% | 2,085,089 +117,241 | +6% | +$4.26M |
|
8
Solid Biosciences
SLDB
$427M
| $72.1M | 4.2% | 2,689,444 | – | – |
|
|
MYOV
9
DELISTED
Myovant Sciences Ltd.
MYOV
| $60.9M | 3.55% | 3,711,549 +259,690 | +8% | +$4.26M |
|
|
EIDX
10
DELISTED
Eidos Therapeutics, Inc. Common Stock
EIDX
| $59.2M | 3.45% | 2,162,671 | – | – |
|
11
Crinetics Pharmaceuticals
CRNX
$2.92B
| $56.2M | 3.27% | 1,875,209 +174,192 | +10% | +$5.22M |
|
12
Rhythm Pharmaceuticals
RYTM
$6.85B
| $52.4M | 3.05% | 1,950,332 | – | – |
|
|
IMMU
13
DELISTED
Immunomedics Inc
IMMU
| $43.1M | 2.51% | 3,021,466 -98,312 | -3% | -$1.4M |
|
14
Arvinas
ARVN
$568M
| $40.3M | 2.35% | 3,138,412 | – | – |
|
|
RARX
15
DELISTED
Ra Pharmaceuticals, Inc. Common Stock
RARX
| $34M | 1.98% | 4,858,260 +1,006,452 | +26% | +$7.04M |
|
16
TG Therapeutics
TGTX
$4.65B
| $33.6M | 1.96% | 8,198,337 | – | – |
|
17
KalVista Pharmaceuticals
KALV
$678M
| $28.5M | 1.66% | 1,441,070 | – | – |
|
|
MNTA
18
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
| $28.2M | 1.64% | 2,558,357 +1,000,000 | +64% | +$11M |
|
|
DRNA
19
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $26.3M | 1.53% | 2,456,669 -1,476,820 | -38% | -$15.8M |
|
|
EIGR
20
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
| $24.5M | 1.43% | +2,415,458 | New | +$24.5M |
|
21
Iovance Biotherapeutics
IOVA
$807M
| $24.1M | 1.4% | 2,720,452 +1,599,299 | +143% | +$14.2M |
|
|
22
Moderna
MRNA
$9.37B
| $23.1M | 1.35% | +1,514,326 | New | +$23.1M |
|
23
KALA BIO
KALA
$78.8M
| $22.2M | 1.29% | 4,537,478 +2,424,242 | +115% | +$11.9M |
|
24
scPharmaceuticals
SCPH
$295M
| $10.7M | 0.63% | 2,857,143 | – | – |
|
25
Protara Therapeutics
TARA
$120M
| $3.04M | 0.18% | 1,337,462 | – | – |
|